Last reviewed · How we verify
NCT06594224
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
NA trial testing Ibuprofen in Pain Management in 80 participants. Completed in 31 August 2024.
31 August 2024
Quick facts
| Lead sponsor | Muhammad Aamir Latif |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 March 2024 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 2 locations across Pakistan |
Drugs / interventions tested
- Ibuprofen (ibuprofen) — full drug profile →
- Nalbuphine — full drug profile →
Conditions studied
- Pain Management — all drugs for Pain Management →
Sponsor
Muhammad Aamir Latif — full company profile →
Who can join
Adults 18 to 45, female only, with Pain Management. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region. The findings of this study would add to the existing data and would be helpful for health providers to opt for a better option for postoperative pain relief following a cesarean section under general anesthesia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of IV Nalbuphine versus ibuprofen for Postoperative Pain control in cesarean section.
Khakwani M, Parveen R, Sultana H. · · 2025 · PMID 41070313 · DOI 10.12669/pjms.41.9.11016
Verify or expand the search:
- PubMed search for NCT06594224
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ibuprofen
Trials testing the same drug.
- NCT07401927 — Preemptive Analgesia in Laparoscopic Hysterectomy · not yet recruiting
- NCT07565012 — Comparative Evaluation of Diclofenac Sodium and Ibuprofen for Post-Endodontic Pain Management · Phase 4 · completed
- NCT06671002 — Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial · Phase 4 · recruiting
- NCT06505148 — Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminop · Phase 4 · not yet recruiting
- NCT05935306 — Effect of Photobiomodulation to Reduce Post-operative Pain After Endodontic Surgery · NA · recruiting
Other recruiting trials for Pain Management
Currently open trials in the same condition.
- NCT07369024 — Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults · Phase 2 · recruiting
- NCT07410000 — Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
- NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
- NCT07442539 — The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery · NA · recruiting
Other Muhammad Aamir Latif trials
Trials by the same sponsor.
- NCT07462182 — Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction · NA · not yet recruiting
- NCT07426744 — Antipyretic Therapy With and Without Cold Sponging · NA · not yet recruiting
- NCT07437391 — Effect of L-Carnitine Supplementation in Preterm Neonates · NA · recruiting
- NCT07313670 — Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock · NA · not yet recruiting
- NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06594224 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muhammad Aamir Latif
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06594224.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing